0001179110-19-010410.txt : 20190917
0001179110-19-010410.hdr.sgml : 20190917
20190917163009
ACCESSION NUMBER: 0001179110-19-010410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190916
FILED AS OF DATE: 20190917
DATE AS OF CHANGE: 20190917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Munch Mark
CENTRAL INDEX KEY: 0001544635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 191097402
MAIL ADDRESS:
STREET 1: BRUKER CORPORATION
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
4
1
edgar.xml
FORM 4 -
X0306
4
2019-09-16
0
0001109354
BRUKER CORP
BRKR
0001544635
Munch Mark
BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
0
1
0
0
Exec VP&Pres Bruker Nano Inc.
Common Stock
2019-09-16
4
M
0
15059
20.04
A
96063
D
Common Stock
2019-09-16
4
M
0
16144
20.68
A
112207
D
Common Stock
2019-09-16
4
M
0
16000
19.82
A
128207
D
Common Stock
2019-09-16
4
S
0
47203
42.8652
D
81004
D
Stock Option (Right to Buy)
20.04
2019-09-16
4
M
0
15059
0
D
2023-08-30
Common Stock
15059
0
D
Stock Option (Right to Buy)
20.68
2019-09-16
4
M
0
16144
0
D
2024-08-08
Common Stock
16144
0
D
Stock Option (Right to Buy)
19.82
2019-09-16
4
M
0
16000
0
D
2025-08-07
Common Stock
16000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.74 to $43.045, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested in four approximately equal annual installments on August 30, 2014, 2015, 2016 and 2017.
The option vested in four approximately equal annual installments on August 8, 2015, 2016, 2017 and 2018.
The option vested in four approximately equal annual installments on August 7, 2016, 2017, 2018 and 2019.
/s/ Michael Rich, Attorney-in-Fact
2019-09-17